MyoStrain for Patients
MyoStrain is a new generation of advanced MRI imaging that measures how your heart muscle moves and contracts without radiation, needles, or contrast dye.
The entire test takes less than 10 minutes and feels just like a regular MRI scan.
It helps your doctor see early changes in heart function long before symptoms appear, so you can protect your heart sooner.
“It was quick and completely painless. I was done before I realized it started.”
— Sarah M., breast cancer survivor
“Knowing my Myohealth gave me peace of mind.”
— Mark T., patient with hypertension
“No contrast, no injection, just breathing normally and my doctor could explain my results quickly”
— Elena R., long-COVID patient
FAQs
What is MyoStrain?
MyoStrain is a rapid and MRI heart scan performed in under 10 minutes. It measures how the heart muscle contracts, helping physicians detect early heart dysfunction before symptoms appear.
Why is MyoStrain important?
Heart disease often develops silently. MyoStrain helps doctors to identify early, reversible changes in heart function so treatment can begin before permanent damage occurs. It enables prevention and personalized care.
Who is MyoStrain for?
MyoStrain is for anyone who wants to understand their heart health and is eligible for an MRI. It is especially recommended for individuals with hypertension, diabetes, obesity, a history of cancer treatment…
How does the test work?
The scan is completed in less than 10 minutes and requires no injections, contrast agents, or breath-holding. MyoStrain analyzes how each part of the heart contracts across 48 regions and produces a MyoHealth® Score, a single number that shows the percentage of the heart muscle functioning normally.
Is MyoStrain safe?
Yes. It is a non-invasive test with no radiation, no contrast dye, and no pharmacologic stress agents. The only requirement is that the patient is MRI-compatible (for example, without pacemakers or certain metal implants).
Where was MyoStrain developed?
MyoStrain was developed at Johns Hopkins University by Dr. Nael Osman, PhD. It has been validated in more than 500 peer-reviewed studies and received FDA 510(k) clearance in 2019.